Tofacitinib for juvenile idiopathic arthritis - Authors' reply. Ruperto N, Brunner HI, Posner HB, Lazariciu I, et al. Lancet 2022;399:1866.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ruperto N, Brunner HI, Posner HB, Lazariciu I, et al. Tofacitinib for juvenile idiopathic arthritis - Authors' reply. Lancet 2022;399:1866.
PMID: 35569465